Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis

NCT03209219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Behçet Disease
Uveitis

Interventions

DRUG: Interferon Alfa-2A
DRUG: Cyclosporine Pill

Sponsor

Peking Union Medical College Hospital